Balaji Amines Limited commenced commercial production at its Acetonitrile (ACN) plant in Solapur on September 24, 2026. The facility now operates with an enhanced installed capacity of 1,440 tonnes per month (TPM).

The commissioning marks the completion of the expansion and modernisation programme for the unit located at Chincholi MIDC. The company utilised advanced technology to upgrade the plant, which serves both domestic and international markets.

Capacity and market scope

The newly commissioned plant is part of the company's Unit III operations. The move strengthens Balaji Amines' position in the speciality chemicals sector by increasing supply availability for key industrial applications.

Regulatory compliance

The intimation was filed with BSE and NSE under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure confirms the date of launch as September 24, 2026. No specific country names were listed for international launches in the initial filing, marked as NA.

Balaji Amines Limited will host analysts and institutional investors for a plant visit and management meet on August 25, 2026, at its facility in Solapur, Maharashtra. The interaction aims to provide participants with an overview of operations based on publicly available data.

The company notified the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the schedule. The disclosure was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Abhijeet Kothadiya, Company Secretary and Compliance Officer, signed the intimation on August 17, 2026.

Event details

The following table outlines the key details of the scheduled analyst interaction:

Management stated that discussions during the visit will be strictly confined to publicly available information. No unpublished price-sensitive information (UPSI) will be disclosed to participants. The company noted that changes to the schedule may occur due to exigencies on the part of either the participants or the company.

Investors can access the latest investor presentation on the company's website. The firm emphasised compliance with regulatory norms while facilitating transparency for market intermediaries.